Core Viewpoint - The Hong Kong capital market has seen a significant increase in refinancing activities at the beginning of 2026, with over HKD 27 billion raised, marking a more than 20-fold increase compared to the same period in 2025, setting a vibrant tone for the year ahead [1][3]. Group 1: Active Refinancing at the Start of 2026 - As of January 18, 2026, Hong Kong-listed companies have raised over HKD 27 billion through various methods such as placements and rights issues, compared to HKD 1.1 billion in the same period of 2025 [1][3]. - The robust refinancing activity is built on the historical high of HKD 325.32 billion in 2025, which surpassed the IPO fundraising scale for the first time [3]. - Major companies like BYD and Xiaomi have completed significant fundraising projects, contributing to a trend of continuous capital replenishment [3]. Group 2: Structural Characteristics of Refinancing - The refinancing activities in early 2026 are characterized by a diverse industry distribution, including sectors like oil and gas, construction, software services, and healthcare [7]. - Notable companies such as SF Express and Jitu Express have raised over HKD 1 billion, indicating a clear differentiation in fundraising scales [7]. - The use of raised funds is closely aligned with core business strategies, including international expansion, technology R&D, and financial structure optimization [7]. Group 3: Advantages of Hong Kong's Refinancing Market - The efficiency of Hong Kong's refinancing system allows companies to quickly seize market opportunities without prior regulatory approval for placements [4]. - The flexible and diverse financing tools available in the Hong Kong market cater to various corporate needs, enhancing the ability to raise funds [5]. - The market's recovery and valuation improvements since Q3 2024 have created a favorable environment for refinancing activities [5]. Group 4: Emerging Trends in Refinancing - The refinancing landscape is evolving, with a notable increase in strategic mutual holdings among companies, exemplified by the collaboration between SF Express and Jitu Express [8]. - The current refinancing structure shows a higher proportion of traditional and consumer industries compared to emerging sectors, highlighting the complementary nature of Hong Kong and A-share markets [8]. - Future trends indicate that refinancing will remain high but with a more stable growth rate, and the focus will shift towards optimizing capital structures and enhancing R&D capabilities [10].

Core Viewpoint - Shanghai aims to build a world-class high-end industrial cluster with advanced manufacturing as the backbone, as outlined in the "15th Five-Year Plan" [3][4]. Group 1: Modern Industrial System - The "2+3+6+6" modern industrial system includes two transformations of traditional industries (digitalization and greening), three leading industries (integrated circuits, biomedicine, and artificial intelligence), six emerging pillar industries (new generation electronic information, smart connected vehicles, high-end equipment, advanced materials, new energy and green low-carbon, and fashion consumer goods), and six future industries (future manufacturing, future information, future materials, future energy, future space, and future health) [3][4]. Group 2: Traditional Industries - Shanghai's traditional industries show strong support, high efficiency, and high-tech characteristics, with a revenue profit margin of 6.2% in 2024, exceeding the national average by 0.8 percentage points [5]. Group 3: Leading Industries - The plan emphasizes the development of three leading industries: enhancing the integrated circuit industry's capabilities, promoting biomedicine through innovative drug development, and advancing artificial intelligence through comprehensive innovation [6][7]. Group 4: Service Industry Development - The plan focuses on the high-quality development of the service industry, aiming to extend the productive service sector towards specialization and high-value chains, while also enhancing the quality of life services [7]. Group 5: Artificial Intelligence Growth - By 2025, the annual tasks of the "Shanghai Plan" for artificial intelligence are expected to be completed, with the AI industry projected to exceed 550 billion yuan in scale, growing at over 30% [8].

有这样一位"国之大医"：他创立了急性早幼粒细胞白血病的"上海方案"，攻克了最凶险的一种白血病， 并且放弃申请专利，只为让更多的病人"吃得起药"；他潜心研究血栓和止血，建设了血友病中国诊疗体 系，将中国相关血液学研究提升到国际先进水平；他二十年每周"开卷考试"，深入思考和诊治疑难病 例，言传身教，培养出一片血液学"人才森林"，还造就了"一门四院士"的传奇…… 他是共和国勋章获得者、中国工程院院士、上海交通大学医学院附属瑞金医院终身教授王振义。 共和国勋章获得者、中国工程院院士、上海交通大学医学院附属瑞金医院终身教授王振义 在长篇纪实文学《大医无疆——共和国勋章获得者王振义》中，《人民日报》高级记者、复旦大学特聘 教授李泓冰与瑞金医学专家朱凡以三十万字篇幅完整再现了王振义的百年人生。 近日，由交大医学院与上海世纪出版集团主办，附属瑞金医院、上海文艺出版社承办的"大医无疆·功勋 炳耀"王振义院士功勋精神研讨会暨《大医无疆——共和国勋章获得者王振义》新书发布仪式在上海交 通大学医学院举行。 《大医无疆——共和国勋章获得者王振义》由上海文艺出版社出版 活动现场 中国科学院院士、四大慢病重大专项技术总师陈竺表示，王振义院 ...

经过三年改革深化提升行动，浦东国资经济效益实现跨越增长，区属企业资产总额达1.15万亿元，营业 收入1153亿元，两项指标均实现两位数增长，为区域经济社会发展提供了有力支撑。 浦东新区国资委主任张福军表示，浦东国资布局持续优化完善，围绕产业发展与民生保障等领域，组建 浦东资本、浦盛集团，推动城市更新、养老、水务、土地征收等板块重组，有效促进了资源向优势主业 和优势企业集聚，提升了国有资本服务区域战略的整体效能。 同时，浦东国资的产业生态建设扎实推进，构建形成"2+X"国资创投矩阵，组建三大国资母基金群，管 理规模超600亿元，基金实现三大先导、六大硬核及类脑智能等未来产业全覆盖；在生物医药、集成电 路等重点产业领域布局8家产业平台公司，推动产业投资占比从10%提升至近40%，企业创新能力和产 业能级同步增强。 改革标志性项目亮点纷呈，成功推动张江公募REITs、外高桥工业厂房持有型不动产ABS、陆家嘴股份 定向增发等一批全国首批、首单资本运作标杆项目落地，进一步彰显了浦东国资国企在深化改革、转型 发展方面的活力。 浦东资本与浦发集团、创投集团交接标的资产 浦东新区最新成立一家注册资本达100亿元的专业化资本运 ...

Core Viewpoint - The Shanghai Municipal Party Committee has released a proposal for the 15th Five-Year Plan, aiming to transform Shanghai into a world-class socialist modern international metropolis by 2035, with a focus on high-quality development and regional integration in the Yangtze River Delta [1]. Group 1: Five Centers Upgrade - Shanghai aims to upgrade its "Five Centers" by 2035, achieving international leading levels in key development indicators, including doubling per capita GDP from 2020 levels [2]. - During the 14th Five-Year Plan, Shanghai's GDP surpassed 5 trillion yuan, becoming the first city in China to achieve this milestone and ranking among the top five global cities [2]. - The upgrade of the "Five Centers" will enhance resource allocation for the Yangtze River Delta, transitioning from single-function enhancement to system integration [2][3]. Group 2: Implementation Paths - The proposal outlines three implementation paths: leveraging financial support for innovation, creating regulatory innovations, and fostering new productive forces to reshape industrial chains [3]. - Shanghai's economic growth is projected to remain reasonable and synchronized with national trends, with a steady increase in total factor productivity [3]. Group 3: Key Industries - The three leading industries—integrated circuits, biomedicine, and artificial intelligence—will further solidify their positions, focusing on overall breakthroughs in the industrial chain [4]. - The artificial intelligence sector is expected to grow significantly, with projected revenues exceeding 550 billion yuan by 2025, reflecting a growth rate of over 30% [4]. Group 4: Institutional Innovation - High-level openness is a core advantage for Shanghai, with institutional innovations aimed at enhancing regional development dynamics [6]. - The proposal emphasizes the role of the Pudong New Area and Lingang New Area in driving institutional innovation and creating replicable models for the Yangtze River Delta [6][7]. Group 5: Collaborative Development - The proposal aims to establish a "power community" in the Yangtze River Delta, focusing on collaborative technological innovation, ecological protection, and spatial optimization [10]. - Specific paths for collaboration include deepening the integration of innovation chains and enhancing cooperation in key technology areas [11]. Group 6: Environmental and Spatial Optimization - The proposal highlights the importance of ecological protection and spatial layout optimization to enhance collaborative capacity in the Yangtze River Delta [12]. - Shanghai will promote the construction of a metropolitan area with a multi-node structure, facilitating coordinated development with surrounding regions [12]. Group 7: Social Welfare and Integration - The proposal emphasizes the sharing of public services across the Yangtze River Delta, enhancing the quality of life for residents in education, healthcare, and other areas [13]. - Shanghai's successful experiences in community services will be extended to the Yangtze River Delta, ensuring that high-quality development benefits a broader population [13].

Core Insights - The signing ceremony in Tianjin Jinghai resulted in 46 quality projects with a total investment of 9.922 billion yuan [1] - The projects span key sectors such as circular economy, biomedicine, equipment manufacturing, new materials, light industry, and modern services [1] - A platform named "Jingxin Office" has been established to provide comprehensive service measures for a favorable business environment, fostering project growth [1] Project Details - 36 of the signed projects will be located in advantageous clusters such as the Tianjin Ziya Economic and Technological Development Zone's circular economy industrial area and high-tech industrial park [1] - An example project is the smart electric vehicle manufacturing park, which plans to invest 1.45 billion yuan and cover an area of 481 acres, complementing local companies like Aima Technology [1] - The focus is on creating synergies among projects to enhance quality and reduce costs in product manufacturing [1]

Economic Growth - The overall economy achieved stable growth, with GDP growth projected at 5% for the year, reflecting a recovery and improvement trend [1] - Quarterly GDP growth rates for 2025 are forecasted at 5.4%, 5.2%, 4.8%, and 4.5% respectively [1] - China's trade surplus reached a historic high of over $1.1 trillion, showcasing the competitiveness of Chinese export products [1] Domestic Demand - The main issue in domestic demand is the imbalance of strong supply versus weak demand, with stable prices indicating insufficient demand [1] - Policies to stabilize consumption include promoting trade-in programs and subsidies for certain products, which have positively impacted sales [1] - Retail sales growth remains relatively low, indicating the need for further policies to enhance residents' income and unlock greater consumption potential [1] Income Disparity - Rural residents experienced a real income growth rate of 6%, significantly higher than the 4.2% growth for urban residents, indicating structural improvement [2] - The decline in labor demand in some urban factories has led to a return of laborers to rural areas, contributing to faster income growth in rural regions [2] Investment Opportunities - The new energy sector is witnessing a differentiated market, with some areas showing profit improvements while others face significant losses, emphasizing the need for value investment [3] - The stock market is currently in a phase of adjustment, with expectations for stronger performance around the Spring Festival [4] - The technology sector is expected to remain a dominant feature, with emerging industries such as robotics, semiconductor chips, and biomedicine identified as beneficiaries of economic transformation [3][4]

Core Insights - The biopharmaceutical industry is a strategic pillar for Guangdong Province and Guangzhou, with a goal to establish a 400 billion yuan biopharmaceutical and health industry cluster within five years [2] - Guangzhou has over 6,500 biopharmaceutical companies, forming a complete and mature industrial ecosystem [2] - A comprehensive service platform for the export of pharmaceutical and medical products has been established, led by Guangzhou Pharmaceutical Group and two other companies [2] Group 1 - Guangzhou Pharmaceutical Group aims to "rebuild a new Guangzhou Pharmaceutical" during the 14th Five-Year Plan, focusing on modernization, digitalization, technological advancement, and internationalization [2] - The establishment of the export service platform is intended to integrate quality resources and provide one-stop professional services for the export of pharmaceutical and medical products [2] - The platform is expected to inject new momentum into the transformation of innovative achievements in Guangzhou's biopharmaceutical industry and facilitate international market expansion [2] Group 2 - Baiyunshan Xihe Health Company has developed four new types of medical radionuclides and is collaborating with over 30 leading hospitals and enterprises on the development of radiopharmaceutical pipelines [3] - The company plans to establish a collaborative innovation consortium for nuclear medicine, focusing on international expansion strategies targeting the EU and ASEAN [3] - Radiopharmaceuticals are crucial for early and precise imaging of diseases like tumors and for targeted delivery of radioactive isotopes to tumor cells, showcasing significant value in various medical fields [3]

Market Overview - The Hong Kong stock market experienced a decline, primarily driven by weakness in financial and technology stocks, with the Hang Seng Index falling by 1.05% to 26,563.90 points [2] - The Hang Seng Technology Index dropped by 1.24% to 5,749.98 points, while the Hang Seng China Enterprises Index decreased by 0.94% to 9,134.45 points [2] Technology Sector Performance - Major technology stocks showed weak performance, with Alibaba down by 3.49% and a trading volume of approximately 11.7 billion HKD. Other notable declines included Meituan, JD.com, and Tencent, each falling over 1% [4][5] - AI application stocks continued to decline, with significant drops in companies like MINIMAX-WP, Huya Technology, and Zhihui, all experiencing declines exceeding 10% [6][7] Biopharmaceutical Sector - The Hang Seng Biotech Index fell by 3.06%, with key constituents such as Kelun-Biotech, InnoCare Pharma, and BeiGene also reporting losses [8] - Despite the downturn, there are indications of improvement in the biopharmaceutical research service sector, with expectations of double-digit growth in new orders for several CRO companies due to an accelerating demand for innovative drugs [8] Precious Metals and Defensive Sectors - The precious metals sector saw a surge, with international gold prices reaching historical highs, leading to significant gains in stocks like Datang Gold and Mengjin Garden, which rose by 8.77% and 5.38% respectively [11] - Defensive sectors, including oil and gold, remained active amid market volatility, with companies like Sinopec and Kunlun Energy showing positive performance [12] Company-Specific Developments - New World Department Store China experienced a notable stock price increase of 29.51%, attributed to recent management changes within the company [13]

Market Overview - The Hong Kong stock market experienced a decline, primarily driven by weak performances in the financial and technology sectors. The Hang Seng Index fell by 1.05% to close at 26,563.90 points, while the Hang Seng Technology Index dropped by 1.24% to 5,749.98 points, and the Hang Seng China Enterprises Index decreased by 0.94% to 9,134.45 points [4][5]. Sector Performance - Major technology stocks showed collective weakness, with Alibaba down by 3.49% and a trading volume of approximately HKD 11.7 billion. Other notable declines included Meituan, JD.com, and Tencent, each falling over 1% [7][8]. - AI application stocks continued their downward trend, with companies like YaoShibang, Ping An Good Doctor, and Alibaba Health experiencing declines of 5.44%, 4.41%, and 3.53% respectively. MINIMAX-WP, Huizhong Technology, and Zhipu saw drops exceeding 10% [10][12]. Biotech Sector - The Hang Seng Biotech Index fell by 3.06%, with key constituents such as Kelun-Biotech, InnoCare Pharma, and BeiGene also closing lower. Despite this, the CRO industry is reportedly improving, with a positive outlook for 2026 due to increased demand for innovative drugs and a recovering financing environment [14][15]. Safe-Haven Assets - The gold sector showed resilience, with international gold prices reaching historical highs, pushing up the prices of Hong Kong-listed gold companies like Datang Gold and Mengjin Garden, which rose by 8.77% and 5.38% respectively [17][18]. Company News - New World Department Store China saw a significant stock price increase of 29.51%, closing at HKD 0.395 per share. This surge followed recent announcements of management changes within the company [20][21].